The extent of synovial cell proliferation in situ and its relationship to the destructive potential of rheumatoid arthritis (RA) is a matter of continuing debate. Notably, the situation has not been elucidated in other inflammatory arthritides [i.e. reactive (ReA) and psoriatic (PsA)], which, although they share some histopathological similarities with RA, develop different patterns of joint involvement. In order to estimate the proliferation of synovial cells in situ in PsA and ReA, and to compare this with RA and with 'non-inflammatory' joint lesions, we have utilized immunostaining of the Ki-67 antigen complemented with Ki-67/CD68 or Ki-67/leucocyte common antigen (LCA, clones 2B11 and PD7/26) double stainings to assess the extent of mononuclear inflammatory cell proliferation. Synovial samples analysed were from 33 patients: RA (n = 8), PsA (n = 13), ReA (n = 6) and six 'non-inflammatory controls' (degenerative or traumatic joint lesions). Thickening of the synovial lining (in particular in RA) and perivascular accumulations of mononuclear inflammatory cells, predominantly lymphocytes, were characteristic features in all synovitides. In contrast to the thickened avascular synovial lining in RA, in 5/13 cases with PsA, blood vessels were observed in the lining. . In this respect, the differences between different forms of the inflammatory arthritides were not statistically significant (P > 0.05). In RA, PsA and ReA, the percentage of labelled cells in the inflammatory mononuclear cell-rich areas was higher than in controls. The percentage of proliferating endothelial cells was also significantly higher in RA, PsA and ReA than in controls. However, in RA, endothelial expression of Ki-67 antigen was often seen in small blood vessels, whereas in PsA, Ki-67 antigen was preferably expressed in the medium to large blood vessels. Synovial lining cells of the monocyte/macrophage lineage (type A synoviocytes), but not stromal monocytes, demonstrated modest proliferation in situ. These results indicate that although proliferation of synovial lining fibroblasts is a prominent feature in RA, the extents to which this, or in situ proliferation of lymphocytes, contribute to the histopathology of PsA, ReA and RA are comparable. Vascular involvement is suggested by the proliferation of endothelial cells in RA, PsA and ReA in an overlapping manner, but, based on topological differences, such a response may represent diverse pathological features, such as angiogenesis, vascular enlargement and reparative responses to injury.
P (PsA), reactive (ReA) and rheumatoid ( RA) situ division/proliferation, and that the extent of these arthritides are inflammatory joint disorders characterprocesses may relate directly to the destructive potenized by activation of the cellular immune response tial of arthritis. Because inflammatory cell recruitment evolving to synovial inflammation/synovitis [1] [2] [3] [4] [5] [6] .
and cell proliferation can be inhibited pharmacoloHowever, these arthritides almost always have differgically, their quantitative assessment in different arthences in clinical course and in the pattern of joint ritic conditions is an important issue. In this context, damage [5] [6] [7] [8] .
a comparatively low proportion of macrophages and RA, PsA and ReA represent some overlap histounremarkable synovial lining hyperplasia in PsA, as pathologically in that their activated synovial tissue is compared with RA, has been suggested to be due characterized by the inflammatory cell infiltration and to different vascular expression of ELAM-1 [9] . hyperplasia of synovial lining. It is postulated that Quantitative similarities in the number of B cells, these features are dependent on cells that have homed T cells and T-cell subsets (predominantly CD4, from circulation and/or cells that may derive from in CD45RO+ T cells) in PsA and RA have been associated with the similar expression of ICAM-1 and VCAM-1 [9, 10] . The question of synovial cell prolifSubmitted 12 December 1996; revised version accepted 23 June eration in RA has been addressed in numerous earlier 1997. studies [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . The findings appear contradictory,
Correspondence to: A. Č eponis, ORTON Research Institute, Tenholantie 10, PO Box 29, 00281 Helsinki, Finland. however, and there still seems to be no firm consensus © 1998 British Society for Rheumatology as to the extent of synovial lining cell proliferation in respectively) prior to synovial biopsy. Of the 33 patients, only one with PsA had previously undergone RA [22] . Furthermore, as noted elsewhere [22] , recent observations on the similar expression of different synovectomy. Of the RA patients, four have been receiving daily non-steroidal anti-inflammatory oncogenes (including c-myc, the oncogene associated with cell proliferation) and oncoproteins in various drugs (NSAIDs) alone, one chloroquine (DelagilA, 200 mg) + NSAID, one steroids (7.5 mg equivalent to arthritic conditions [23, 24] have raised the question 'to what extent' are the local expression of oncogenes prednisolone), one sulphasalazine (1.5 g) + steroids (10 mg equivalent to prednisolone) + NSAID; one of as well as the in situ proliferation of synovial cells specific to the RA lesion? Thus, characterization of the the RA patients had no systemic medication. Of the PsA patients, one has been receiving daily steroids synovial cell proliferation in situ in other (than RA) inflammatory arthritides seems to be required. A dis-(5 mg equivalent to prednisolone) + NSAID, one sulphasalazine (1.5 g) + NSAID, one allopurinol + tinct, though not less interesting question, is the proliferation of endothelial cells, a process/step essential for NSAID, two NSAID alone, one has been treated with massive doses of steroids due to allergy to sulphasalathe formation of new blood vessels/angiogenesis, which has been proposed to be an important pathogenetic zine, and six had no systemic medication. One of the PsA patients has been treated with fumaderm + mechanism promoting PsA and RA [4, 8, [25] [26] [27] . However, synovial endothelial proliferation has not local steroid salve for the skin. Of the patients with ReA, two had no medication, four have been receiving been elucidated.
The present study was undertaken to quantify and NSAIDs; one of the latter had received antibacterial therapy before synovial biopsy. [29] , antigenic epitopes for Dako rabbit anti-human Ki-67 antigen (affinity-isolated antidiagnostic arthroscopy. Eight of the patients (two men and six women; mean age 46.6 yr, range 31-73) had body) were disclosed using the microwave antigenretrieval technique by boiling tissue sections in 10 m RA [30] (mean duration of the arthritis 8 yr, range 3-15), 13 (nine men and four women; mean age citrate buffer (pH 6.0) twice for 5 min in a microwave with a rotating table at a power of 600 W. After 37.2 yr, range 7-64) had PsA [31] (mean duration of the arthritis 7.5 yr, range and six (two men and cooling at room temperature for 20 min in citrate buffer, the sections were washed with distilled water, four women; mean age 29.8 yr, range 19-53) had ReA [32] [duration of the arthritis 3 days (two cases), 1 yr 0.1  phosphate-buffered saline (PBS), pH 7.4, and serially incubated in: (1) normal goat serum (diluted (two cases), 3 yr (one case), and in one case recurrent arthritis for 12 yr]. Specimens from six patients (three 1:50; Vector Laboratories, Burlingame, CA, USA) for 45 min, (2) affinity-isolated primary antibody, Dako men and three women; mean age 41.2 yr, range 28-63) were used as controls; these synovial samples were rabbit anti-human Ki-67 antigen (diluted 1:400; Dakopatts A/S, Glostrup, Denmark) overnight at from joints with osteoarthritis (OA) (N = 2) [33] , meniscus lesion (N = 2), distortion of the knee joint +4°C, (3) biotinylated goat anti-rabbit immunoglobulin G (diluted 1:130; Vector Laboratories) for (N = 1) and knee chondromatosis (N = 1).
Each of the patients with PsA had psoriatic skin 45 min, (4) avidin-biotin-peroxidase complex ( Vector Laboratories) for 45 min and (5) 3,3∞-diaminobenzidine disease. A test for rheumatoid factor was negative in each of the seven PsA patients tested.
tetrahydrochloride (DAB) (Sigma Chemical Co., St Louis, MO, USA) in 0.006% H 2 O 2 PBS solution. Of the patients with ReA, arthritis had been triggered by chlamydial infection in four cases, in one by Consecutive tissue sections were left without counterstain or counterstained with haematoxylin. After Salmonella infection, and in one case ReA had developed after pharyngitis (no Salmonella, Yersinia, washing in tap water, sections were dehydrated in alcohol series, cleared in xylene, and mounted Campylobacter or chlamydial antibodies were found in the blood ). Of ReA patients, five were HLA B27+.
in a synthetic mounting medium Diatex (Becker Industrifärg AB, Märsta, Sweden). Bovine serum albuAll the ReA patients recovered during the follow-up.
Of the 33 patients included in this study, only two min, 0.1% in PBS, was used for dilution of serum and antibodies. Between each step (except after incubation patients with PsA had intra-articular steroids during the period less than 3 months (4 weeks and 5 weeks, with normal goat serum), the slides were washed three times for 5 min in PBS. Omission of the primary synovial lining cells, 500 endothelial cells and 500 cells in the mononuclear cell-rich areas (in RA, PsA, ReA) antibody, use of normal rabbit IgG instead of specific primary antibodies, and exposure of tissue sections to or perivascular areas (in control samples). The cell counting was performed by two observers (AC and DAB served as negative staining controls. YTK ), independently. One of the observers was unaware of the patients' identities/source of the sample.
Protocol of ABC-APAAP (alkaline phosphatase-antialkaline phosphatase) double staining
The estimated averages of the labelling ratios were expressed as percentages [28] . ABC-APAAP double staining was carried out and the colour reactions were developed as described in detail elsewhere [34, 35] . Briefly, 5-mm-thick, formalinStatistical analysis Statistical analysis was performed with BMDP-PC fixed, paraffin-embedded consecutive synovial sections from the same specimens, which have been used for 7.01 software. Medians plus interquartile ranges (Q3-Q1) as well as means [95% confidence intervals staining of Ki-67, were first treated as for the staining of Ki-67 using the protocol for the ABC technique (CI )] were used for data presentation. P values for differences between the groups were calculated using (described above) up to the step when the slides were rinsed in tap water. Then, the slides were washed with the Mann-Whitney test for unpaired samples. 0.05  Tris[hydroxymethyl ]aminomethane (Sigma RESULTS Chemical Co., St Louis, MO, USA)-buffered saline ( TBS ), pH 7.4, and incubated in: (1) normal rabbit Histological examination of the synovial samples in the present series of 'controls', i.e. OA, meniscus serum (diluted 1:50; Dakopatts A/S, Glostrup, Denmark), (2) a monocyte/macrophage marker, lesions, distortion of the knee joint and chondromatosis, and overtly inflammatory conditions, i.e. RA, mouse anti-human CD68 IgG (dilution 1:50, Dako A/S, Glostrup, Denmark) for 1 h at +22°C, (7) rabbit PsA and ReA, revealed some shared, but also some distinct, histopathological features. In RA, PsA and anti-mouse IgG (dilution 1:50, Dako A/S, Glostrup, Denmark) for 1 h at +22°C, (8) APAAP solution ReA, thickening of the synovial membrane, due to an increased depth of the synovial lining cells and depos-(dilution 1:25, Dako A/S, Glostrup, Denmark) for 1 h at +22°C. (9) Alkaline phosphatase was visualized ition of extracellular matrix, was a prominent feature, particularly in RA. Out of eight RA cases, six disclosed using 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) and nitroblue tetrazolium (NBT ) as substrate and marked and two occasional hyperplasia of the synovial lining. Out of 13 cases with PsA, three showed no and chromogen, respectively, both diluted in alkaline phosphatase buffer containing 3 m levamisole (to inhibit 10 occasionally mild to moderate hyperplasia. All six cases of ReA had occasionally mild hyperplasia of the activity of tissue endogenous alkaline phosphatase) for 20 min at +22°C in the dark. Finally, the slides were synovial lining. Inflammatory cell infiltrates and perivascular accumulations of the inflammatory monorinsed in distilled water and mounted in Glycergel (Dako A/S, Glostrup, Denmark). No counterstainnuclear cells were an indistinguishable feature of all chronic synovitides. In RA, the cells mainly with the ing was used in this double-staining procedure. Throughout the APAAP staining, between each appearance of lymphocytes often formed large aggregates. Differences were observed in the synovial vasincubation step (except before primary antibodies), the slides were washed with TBS three times for 5 min.
culature/vascularization in PsA and RA. The thickened RA synovial lining was substantially avascular with The above described double-staining technique was used also to stain Ki-67 antigen (ABC staining) and the blood vessels being situated beneath the lining. In contrast, in 5/13 cases with PsA, increased vasculature leucocyte common antigen (LCA, clones 2B11 and PD7/26, Dako A/S, Glostrup, Denmark) (APAAP and large vessels were also observed close to and/or protruding from the synovial lining. In ReA, the staining). In contrast to the many other lymphoid and myeloid cell markers, Dako anti-human LCA (a mixsynovial vasculature resembled that seen in control samples. Thus, the cases with PsA and ReA represent ture of 2B11 and PD7/26 antibodies) is particularly recommended for use on routinely processed, paraffinthe pathomorphological features ascribed to these conditions in some earlier reports [4-6, 8, 36, 37] . embedded specimens. It reacts with the epitopes on LCA chains with a molecular mass of 180, 190, 205 Representative examples of immunostaining/expression of Ki-67 antigen in synovial lining, perivascular and 220 kDa, but is not designed as a CD45 antibody. Dako anti-human LCA (clones 2B11 and PD7/26) mononuclear inflammatory infiltrates and vascular endothelium are shown in Figs 1 and 2 . Combined mainly labels lymphoid cells and is unreactive with the non-haematopoietic cells (for references, see antibody assessment of the Ki-67/CD68 (a monocyte/macrophage marker) (Fig. 3) and Ki-67/LCA (clones 2B11 specification). and PD7/26) ( Fig. 4) double stainings confirmed that, regardless of the inflammatory condition studied, the Microscopic evaluation and quantitative assessment of the synovial labelling absolute majority of the Ki-67 antigen-expressing cells were fibroblast-like cells in the synovial lining and Microscopic examination and cell counting were carried out with a Leitz Diaplan lens system ( Wetzlar, lymphocytes in the inflammatory mononuclear cellrich areas. Only a few lining cells were co-labelled for Germany). Numbers of cells labelled/stained for Ki-67 antigen were counted separately for 500 consecutive Ki-67 antigen and CD68 (Fig. 3B) . The majority of . In this respect, RA, PsA and ReA did not differ from each into the joint cavity were negative for Ki-67 antigen. Endothelial cells expressing Ki-67 antigen were comother (P > 0.05). The percentage of labelled cells in the inflammatory monly seen in the small blood vessels in RA ( Fig. 2A) , whereas in PsA they were preferably observed in the mononuclear cell-rich areas was higher in RA (median = 4.4%, [Q3-Q1] = 6.2, mean [95% CI ] = medium to large blood vessels ( Fig. 2C ) . Notably, four PsA cases, which were characterized by the most 5.5% [1.8-9.3] , P = 0.0029), PsA (median = 6.6%, [Q3-Q1] = 7.6, mean [95% CI ] = 5.8% [3.4-8.1] , advanced synovial changes, showed comparatively small ratios of proliferating endothelial cells ( Fig. 2D) , P = 0.0084) and ReA (median = 8.7%, [Q3-Q1] = 8.2, mean [95% CI ] = 6.5% [2.2-10.9 ], P = 0.0127) whereas, similarly to ReA ( Fig. 2B) , relatively high ratios of the proliferating endothelial cells were found than in the control samples (median = 0.9%, . ABC-APAAP double staining, no counterstain; original magnification ×400. In (A), note expression of CD68 in the cells of synovial lining, which is indicated by arrows. In (B), nuclear expression of Ki-67 antigen (brown in original preparations) is indicated by long arrows, and cytoplasmic CD68 staining (blue in original preparations) is indicated by short arrows: note that in the inflammatory mononuclear cell-rich sublining area Ki-67 antigen and CD68-specific antibodies stain distinct cells, whereas some of the lining cells were found co-expressing these two markers (curved arrow).
expressing Ki-67 antigen in synovial membranes in RA (median = pathological features, such as angiogenesis, vascular although the contribution of in situ proliferation of the macrophage-like cells to the hyperplasia of synovial enlargement and reparative responses to injury.
Proliferation of synovial lining cells was most promlining is little, these cells are able to proliferate. In contrast, this phenomenon was not observed in the inent in RA, intermediate in PsA and ReA, and low in the control samples, with the significant difference mononuclear inflammatory cell-rich areas, where the majority of the proliferating cells were LCA positive, being found between inflammatory arthritides and the 'non-inflammatory' controls. It should be noted that i.e. of lymphoid origin. This suggests that the proliferation of monocyte/macrophages in synovium in arthritis in the original study utilizing synovial staining for Ki-67 antigen, the labelling index was very low may be related to the maturation/differentiation of monocyte/macrophages into specialized type A syn-(0-0.03%) for lining cells in RA [17] . This contrasts with the ratio presented here (median = 4.7%, ovial cells and also to the 'inflammatory state' of the synovial tissue. [Q3-Q1] = 3.9, mean [95% CI ] = 3.5% [1.7-5.2] ) which, however, is close to the results reported in other There was a comparatively high, but very similar overall Ki-67 antigen expression in the LCA-positive studies utilizing other markers of cell proliferation [12, 19] . This discrepancy may be accounted for by some mononuclear cell-rich areas in RA, PsA and ReA. This corresponds to the quantitative similarities of the technical differences. First, we have utilized polyclonal, instead of monoclonal, antibodies [17] . Because polyimmunohistology of these arthritides in this respect [9, 10] and is in keeping with local proliferation of lymphoclonal antibodies recognize several different immunoreactive epitopes, they are not as sensitive to artifacts cytes, usually defined as 'antigen-triggered' T cells [3, 41] . Although RA differs from PsA and ReA in the caused by fixation and sample processing, i.e. the likelihood of false-negative staining is smaller. Second, synovial fluid kinetics of CD4+ and CD8+ T cells [8, 42] , and is characterized by relatively low expression the microwave oven antigen-retrieval technique was utilized in the present study to reveal hidden immunoof T-cell activation markers, namely MHC class II antigen, interleukin-2 and transferrin receptors and gp reactive epitopes. Finally, we analysed the synovial lining through its whole thickness [19] instead of 40/80 glycoprotein (all are already detectable in the G 1 phase of the cell cycle) [1] and [3H ]thymidine incorpcounting the intimal monolayer only [17] . In addition to the proliferation of the fibroblast-like type B lining oration (detectable in the S phase of the cell cycle) [21] in the synovial fluid, these differences do not seem to cells, chronic synovitis may be characterized by a more prominent migration of macrophage-like type A cells be reflected in the overall proliferation of lymphocytes in synovial tissue. into the lining [38] . Despite existing evidence that monocyte/macrophages are able to proliferate [39, 40] , Endothelial cell proliferation seems to characterize, in addition to RA, also PsA and ReA. It was surprising type A synovial lining cells are generally regarded as non-dividing cells. According to the present results on to find out that the ratio of proliferating endothelial cells in ReA did not differ significantly from that seen Ki-67 and CD68 or LCA co-expression, it seems that 5. Fassbender H-G. Inflammatory reactions in arthritis. In: in RA and PsA, which have been characterized as Davies ME, Dingle JT, eds. Immunopharmacology of 'angiogenesis-dependent diseases' [4, 8, 25] . Also, the joints and connective tissue. Academic Press, Harcourt rank order, i.e. RA > ReA > PsA > control samples, Brace and Company, London, 1994:166-98. of the endothelial proliferation apparently does not fit 6. Fassbender H-G. Der psoriatische Knochenprozeß. In: with the rank order of synovial vascularity, i.e. Wollina U, Hein G and Knopf B, eds. Psoriasis und PsA > ReA > non-inflammatory controls > RA [27] . Gelenkerkrankungen: Pathogenese, Klinik, Diagnostic However, these findings are in agreement with an und Therapie der psoriatischen Osteoarthropathie. Jena. involvement of angiogenesis in inflammatory arthrit- Stuttgart, G. Fischer, 1996:65-75. ides. In RA, endothelial expression of Ki-67 antigen 7. Konttinen YT, Nordströ m DC, Bergroth V, LeirisaloRepo M, Santavirta S. Occurrence of different ensuing was commonly seen in small and apparently growing triggering infections preceding reactive arthritis: a follow vessels, while in PsA proliferating endothelial cells were up study. Br Med J 1988; 296:1644-55. preferably observed in the medium to large vessels. sia/growth rate of inflammatory synovial tissue exceed
